Would you ever consider pelvic exenteration followed by SBRT for a patient with recurrent cervical cancer (s/p chemoRT) who has disease only in the central pelvis and in a single hilar lymph node?
Certainly the distant disease makes the risk of recurrence after exenteration very high. On the other hand, the patient is 2 years out from initial treatment and disease seems to be slow-growing.
Community PollStarted
Does the presence of any distant disease automatically render a patient ineligible for pelvic exenteration?
52 physicians have voted
Join Mednetto vote and see how they answered.
2 Answers
Mednet MemberInvited Expert
Gynecologic Oncology · The Ohio State University College of Medicine
Answered on
I think this is a tough question. The short of it would be that I would be very cautious with exent candidacy with extra-pelvic disease. The surgical morbidity and limited ability to get additional therapy are a reality. Scenarios where I might consider would be a long duration of time off therapy. ...
Join for free or sign in to see the full answer
Mednet MemberInvited Expert
Gynecologic Oncology · Washington University School of Medicine
Answered on
I would consider it.
Join for free or sign in to see the full answer